Products

SubmitAI

Boost Your AI Tool SEO – Submit and Succeed!

submitai.pro Marketing / Backlinks & Launch Directories

AI Benchmark
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
No monthly subscription pricing
Creators
Aaron Sun
No social account linkedCo-created with Allen Xu
Launched
2y ago
2024-07-05 · Est.

Traffic

Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Boost AI app's visibility with 200+ directory submissions

    Sep 13, 2024 · 2y agoLaunch page

  • Launched on Uneed (#2)Launch

    SubmitAI — Boost Your AI Tool Traffic & Backlinks, Submit AI Tool to 100+ AI Tools Listing!

    Sep 2, 2024 · 2y agoLaunch page

  • Launched on Product HuntLaunch

    Boost Your AI Tool SEO – Submit and Succeed!

    Jul 5, 2024 · 2y agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2024-06-30

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Pages & changes

Tracked since 2024-07-05

Key pages

Weekly snapshots

No page snapshots yet. Once followed, home and pricing pages are captured weekly.

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does SubmitAI get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is SubmitAI and what platforms does it support?
SubmitAI is catalogued under Backlinks & Launch Directories: Boost Your AI Tool SEO – Submit and Succeed!. Supported platforms: Web.

Related products in this category

Marketing / Backlinks & Launch Directories

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.